poisar

Stocks · News reference

Citigroup Maintains Buy on WAVE Life Sciences, Lowers Price Target to $19

Jul 31, 2026, 8:43 PMBenzinga Newsdesk

Citigroup analyst Samantha Semenkow maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $24 to $19.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

WVE
Source
benzinga
Observed
Jul 31, 2026, 8:43 PM
Checked
Jul 31, 2026, 8:43 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 7, 2026, 8:52 PMSEC EDGAR

    8-K12B filing — Wave Life Sciences, Inc. (WVE)

    Filed: 2026-08-07 AccNo: 0001193125-26-340430 Size: 972 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

    Read original at edgar
    WVE